A. Hinrichs

发表

Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium.

A. Vissink, D. Isenberg, J. Sánchez-Guerrero, 2021, Clinical and experimental rheumatology.

CCL5 Release by CCR9+ CD8 T Cells: A Potential Contributor to Immunopathology of Primary Sjögren’s Syndrome

H. Leavis, J. V. van Roon, A. Kruize, 2022, Frontiers in Immunology.

Deciphering the role of cDC2s in Sjögren’s syndrome: transcriptomic profile links altered antigen processes with IFN signature and autoimmunity

T. Radstake, J. V. van Roon, A. Kruize, 2022, Annals of the Rheumatic Diseases.

Childhood-onset of primary Sjögren's syndrome: phenotypic characterization at diagnosis of 158 children.

A. Vissink, D. Isenberg, X. Mariette, 2021, Rheumatology.

Angiopoietin-2 Promotes Inflammatory Activation in Monocytes of Systemic Sclerosis Patients

W. Marut, T. Radstake, L. Beretta, 2020, International journal of molecular sciences.

In patients with primary Sjögren’s syndrome innate-like MAIT cells display upregulated IL-7R, IFN-γ, and IL-21 expression and have increased proportions of CCR9 and CXCR5-expressing cells

H. Leavis, J. V. van Roon, A. Kruize, 2022, Frontiers in Immunology.

Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c+ Dendritic Cell Dysregulation in Systemic Sclerosis

S. Hiddingh, M. Boes, L. Beretta, 2021, bioRxiv.

SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients

A. Vissink, F. Giardina, D. Isenberg, 2020, Rheumatology.

The Transcriptomic Profile of Monocytes from Patients With Sjögren’s Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating Mediators

J. V. van Roon, A. Kruize, A. Hinrichs, 2021, Frontiers in Immunology.

Transcriptome Analysis of CCR9+ T Helper Cells From Primary Sjögren’s Syndrome Patients Identifies CCL5 as a Novel Effector Molecule

J. V. van Roon, A. Kruize, A. Hinrichs, 2021, Frontiers in Immunology.

Characterization and outcomes of 414 patients with primary SS who developed hematological malignancies.

A. Vissink, D. Isenberg, X. Mariette, 2022, Rheumatology.

CCR9/CXCR5 Co-Expressing CD4 T Cells Are Increased in Primary Sjögren’s Syndrome and Are Enriched in PD-1/ICOS-Expressing Effector T Cells

H. Leavis, J. V. van Roon, A. Kruize, 2023, International journal of molecular sciences.